FOFA FAMILY OFFICE OF AMERICA, INC.
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1871181 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY47.9%
TTM EPS YoY0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-13.4%
ROA-7.4%
ROIC (approx.)-44.8%
Asset turnover—
Leverage & solvency
Liabilities / assets59.1%
Debt / equity0.00x
Current ratio0.75x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-1.93x
Accruals ratio-21.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $221,765 | — | — | — | — |
| Gross profit | $221,765 | — | — | — | — |
| R&D expense | — | — | $1,500 | $76,360 | $500,567 |
| SG&A expense | $516,362 | $96,513 | $152,630 | $596,232 | $922,182 |
| Operating income | -$501,079 | -$96,513 | -$230,241 | -$920,515 | -$1.59M |
| Pretax income | -$492,748 | -$100,484 | -$805,021 | -$920,515 | -$1.73M |
| Net income | -$492,748 | -$100,484 | -$805,021 | -$920,515 | -$1.73M |
| EBITDA | — | — | -$212,991 | -$903,413 | -$1.57M |
| EPS (basic) | -0.02 | 0.00 | -0.09 | -0.11 | -0.25 |
| EPS (diluted) | -0.02 | 0.00 | -0.09 | -0.11 | — |
| Weighted avg. shares (diluted) | 26.68M | 20.26M | 8.48M | 8.33M | 6.93M |
| Banking | |||||
| Net interest income | -$5,678 | -$3,971 | — | — | — |
| Balance sheet | |||||
| Cash & equivalents | $155,798 | $13,586 | $2,431 | $69,858 | $528,284 |
| Receivables | $74,764 | — | — | — | — |
| Inventory | — | — | — | $40,175 | $60,275 |
| Current assets | $270,359 | $20,581 | $2,431 | $256,203 | $743,703 |
| PP&E, net | — | — | — | $39,258 | $56,360 |
| Goodwill | $835,600 | — | — | — | — |
| Intangibles | $437,083 | — | — | — | — |
| Total assets | $1.54M | $20,581 | $2,431 | $295,461 | $800,063 |
| Current liabilities | $578,533 | $44,021 | $525,387 | $71,507 | $29,648 |
| Long-term debt | $300,000 | — | — | — | — |
| Total debt | $300,000 | — | — | — | — |
| Total liabilities | $878,533 | $44,021 | $525,387 | $71,507 | $29,648 |
| Shareholders' equity | $664,509 | -$23,440 | -$522,956 | $223,954 | $770,415 |
| Net debt | $144,202 | — | — | — | — |
| Shares outstanding | 30.20M | 20.44M | 8.44M | 8.48M | 8.24M |
| Cash flow statement | |||||
| Operating cash flow | -$262,188 | -$89,370 | -$76,529 | -$558,426 | -$792,844 |
| Capital expenditure | — | — | — | — | $1,787 |
| Free cash flow | — | — | — | — | -$794,631 |
| Investing cash flow | -$560,600 | — | — | — | -$1,787 |
| Financing cash flow | $965,000 | $100,525 | $9,102 | $100,000 | $1.25M |
| Depreciation & amortization | — | — | $17,250 | $17,102 | $16,953 |
| Stock-based compensation | $137,309 | — | $45,763 | -$94,101 | $166,141 |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.